Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab for refractory ulcerative proctitis.
Bouguen G, Roblin X, Bourreille A, Feier L, Filippi J, Nancey S, Bretagne JF, Flourié B, Hébuterne X, Bigard MA, Siproudhis L, Peyrin-Biroulet L. Bouguen G, et al. Among authors: bigard ma. Aliment Pharmacol Ther. 2010 Jun;31(11):1178-85. doi: 10.1111/j.1365-2036.2010.04293.x. Epub 2010 Mar 8. Aliment Pharmacol Ther. 2010. PMID: 20222911 Free article.
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
Oussalah A, Laclotte C, Chevaux JB, Bensenane M, Babouri A, Serre AA, Boucekkine T, Roblin X, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Among authors: bigard ma. Aliment Pharmacol Ther. 2008 Oct 15;28(8):966-72. doi: 10.1111/j.1365-2036.2008.03811.x. Epub 2008 Jul 24. Aliment Pharmacol Ther. 2008. PMID: 18652603 Clinical Trial.
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression.
Peyrin-Biroulet L, Cadranel JF, Nousbaum JB, Oussalah A, Seddik M, Canva V, Cortot A, Sogni P, Gueant JL, Bigard MA, Roblin X, Bronowicki JP. Peyrin-Biroulet L, et al. Among authors: bigard ma. Aliment Pharmacol Ther. 2008 Oct 15;28(8):984-93. doi: 10.1111/j.1365-2036.2008.03812.x. Epub 2008 Jul 24. Aliment Pharmacol Ther. 2008. PMID: 18657132
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies.
Allez M, Vermeire S, Mozziconacci N, Michetti P, Laharie D, Louis E, Bigard MA, Hébuterne X, Treton X, Kohn A, Marteau P, Cortot A, Nichita C, van Assche G, Rutgeerts P, Lémann M, Colombel JF. Allez M, et al. Among authors: bigard ma. Aliment Pharmacol Ther. 2010 Jan;31(1):92-101. doi: 10.1111/j.1365-2036.2009.04130.x. Aliment Pharmacol Ther. 2010. PMID: 19709098 Free article.
201 results